Agora Disease-Treatment Claims — 2021 Collection

Blossom Nature

FDA targets supplement sellers on Amazon making unapproved disease-treatment claims.

Cancer Center Advertising: When Consumer Education and Regulatory Complaints Aren’t Enough

TINA.org strives to educate clinicians about patient testimonials.

Relief Factor

Are all Relief Factor’s repeat customers willing participants?

Jim Bakker’s Coronavirus ‘Solution’

There’s a reason why certain things aren’t being said about the coronavirus.

Focused Mind Jr.

Where’s the clinical proof for these “clinically proven” claims?

Cali Botanicals

FDA warns that kratom supplements may do more harm than good in combating opioid addiction and withdrawal.

Does Stocking Shelves = Product Promotion?

Texas court lets retailers off the hook for promoting products on shelves.

Ginkgold® Products

Allegations: Falsely advertising supplements as providing brain health benefits

Cobra Sexual Energy

Allegations: Falsely marketing supplements as “scientifically formulated to improve virility” without scientific evidence to support this claim

Curamin Pain Relief Products

Allegations: Falsely advertising that Curamin products relieve pain when there is no scientific evidence showing that curamin relieves pain

Metagenics “Medical Foods”

IV Therapies and COVID-19: The Drip, Drip, Drip of Deceptive Claims

TINA.org finds dozens of clinics deceptively promoting IV therapies as a way to prevent and treat the coronavirus.

Sheer Pre-Workout Workout Enhancer Powder

Juice Plus+ Subscriptions

Allegations: Failing to disclose the terms of subscriptions

TINA.org Files FTC Complaint Against “Brain Training” Company Neurocore

MADISON, CONN. November 12, 2019 – Ad watchdog truthinadvertising.org (TINA.org) has filed a complaint with the Federal Trade Commission (FTC) against Neurocore, a “brain training” company with centers in Michigan…

AdvoCare to Pay $150 Million to Settle FTC Pyramid Charges

Health and wellness products MLM allegedly rewarded recruitment over product sales.

AdvoCare’s 24-Day Challenge and AdvoCare Spark

FDA Tackles CBD

FDA to consider legal pathways for cannabis-derived compound.

By the Numbers: Made in the USA Class-Action Lawsuits

A closer look at the who, what, when, where and why.